Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Al Hanson"'
Autor:
Jolene A. Giacinti, Anthony V. Signore, Megan E. B. Jones, Laura Bourque, Stéphane Lair, Claire Jardine, Brian Stevens, Trent Bollinger, Dayna Goldsmith, Margo Pybus, Iga Stasiak, Richard Davis, Neil Pople, Larissa Nituch, Rodney W. Brook, Davor Ojkic, Ariane Massé, Gabrielle Dimitri-Masson, Glen J. Parsons, Meghan Baker, Carmencita Yason, Jane Harms, Naima Jutha, Jon Neely, Yohannes Berhane, Oliver Lung, Shannon K. French, Lawrna Myers, Jennifer F. Provencher, Stephanie Avery-Gomm, Gregory J. Robertson, Tatsiana Barychka, Kirsty E. B. Gurney, Jordan Wight, Ishraq Rahman, Kathryn Hargan, Andrew S. Lang, William A. Montevecchi, Tori V. Burt, Michael G. C. Brown, Cynthia Pekarik, Trevor Thompson, Angela McLaughlin, Megan Willie, Laurie Wilson, Scott A. Flemming, Megan V. Ross, Jim Leafloor, Frank Baldwin, Chris Sharp, Hannah Lewis, Matthieu Beaumont, Al Hanson, Robert A. Ronconi, Eric Reed, Margaret Campbell, Michelle Saunders, Catherine Soos
Publikováno v:
mBio, Vol 15, Iss 8 (2024)
ABSTRACT Following the detection of novel highly pathogenic avian influenza virus (HPAIV) H5N1 clade 2.3.4.4b in Newfoundland, Canada, in late 2021, avian influenza virus (AIV) surveillance in wild birds was scaled up across Canada. Herein, we presen
Externí odkaz:
https://doaj.org/article/18754202dc1644a89ad0b1ccecde07b5
Publikováno v:
Canadian Journal of Remote Sensing, Vol 47, Iss 1, Pp 65-82 (2021)
The recent world-wide loss of seagrasses, which are critical components of coastal ecosystems, has ignited an effort among scientists and resource managers to develop effective monitoring tools. Although Landsat time-series is considered one of the m
Externí odkaz:
https://doaj.org/article/0f79dcac80bd467083a7b1e68a21a398
Autor:
Paul T. Charles, André A. Adams, Jeffrey R. Deschamps, Scott Veitch, Al Hanson, Anne W. Kusterbeck
Publikováno v:
Sensors, Vol 14, Iss 3, Pp 4074-4085 (2014)
A field demonstration and longevity assessment for long-term monitoring of the explosive 2,4,6-trinitrotoluene (TNT) in a marine environment using an anti-TNT microfluidic immunosensor is described. The TNT immunosensor is comprised of a microfluidic
Externí odkaz:
https://doaj.org/article/533eefe4cf3043f9bb243a095344f89e
Autor:
André A. Adams, Al Hanson, Jeffrey R. Deschamps, Scott P. Veitch, Paul T. Charles, Anne W. Kusterbeck
Publikováno v:
Sensors, Vol 14, Iss 3, Pp 4074-4085 (2014)
Sensors (Basel, Switzerland)
Sensors; Volume 14; Issue 3; Pages: 4074-4085
Sensors (Basel, Switzerland)
Sensors; Volume 14; Issue 3; Pages: 4074-4085
A field demonstration and longevity assessment for long-term monitoring of the explosive 2,4,6-trinitrotoluene (TNT) in a marine environment using an anti-TNT microfluidic immunosensor is described. The TNT immunosensor is comprised of a microfluidic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56792337fc74a37c69241ef40d0e0305
https://doi.org/10.3390/s140304074
https://doi.org/10.3390/s140304074
Autor:
John N. Kemp, Donald B. Peters, Frank Spada, Tommy D. Dickey, Al Hanson, Grace Chang, Oscar Schofield, Scott Glenn, Dave Karl, Casey Moore, Derek Manov
Publikováno v:
OCEANS 2006.
Interdisciplinary time series observations are important for understanding and predicting ocean variability on time scales from seconds to decades. Plans are being made to implement open ocean observatories at key sites in the world ocean (e.g., Ocea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d662443a65209c58f9a5a0127fdc0cc9
https://doi.org/10.1109/oceans.2006.307099
https://doi.org/10.1109/oceans.2006.307099
Autor:
Ed Riseman, Al Hanson
This report summarizes the work done at the University of Massachusetts in the area of Image Understanding of static scene domains. The goal of this research project was to demonstrate a practical knowledge-based approach to computer vision that util
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c740f61d7c0ba46e2eedee0d605668c
https://doi.org/10.21236/ada245661
https://doi.org/10.21236/ada245661
Autor:
Andrew H. Barnard, Casey Moore, Tommy D. Dickey, Grace Chang, J. Ron V. Zaneveld, Al Hanson, Scott McLean, Peter J. Egli
Publikováno v:
Applied Optics. 45:3593
Relationships and variability of bio-optical properties in coastal waters are investigated. Optical proxies indicate that these coastal waters are optically complex and highly variable and are categorized as follows: (1) relatively clear and dominate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc03d05916b83fec0d4ff8d325d3fb9
https://doi.org/10.1364/ao.45.003593
https://doi.org/10.1364/ao.45.003593
Autor:
Hanson AL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Mulè MP; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NIH-Oxford-Cambridge Scholars Program, Department of Medicine, University of Cambridge, Cambridge, UK., Ruffieux H; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Mescia F; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Pelly VS; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Turner L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Göttgens B; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK., Hess C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Gleadall N; Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Botnar Research Centre for Child Health (BRCCH), University of Basel and ETH Zurich, Basel, Switzerland., Bradley JR; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Nathan JA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Drakesmith H; MRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. smith.k@wehi.edu.au.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. smith.k@wehi.edu.au.; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. smith.k@wehi.edu.au.; University of Melbourne, Melbourne, Victoria, Australia. smith.k@wehi.edu.au.
Publikováno v:
Nature immunology [Nat Immunol] 2024 Mar; Vol. 25 (3), pp. 471-482. Date of Electronic Publication: 2024 Mar 01.
Autor:
Bhuyan ZA; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Rahman MA; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Maradana MR; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Mehdi AM; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Bergot AS; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Simone D; Dipartimento di Medicina di Precisione, Section of Rheumatology, Università degli Studi della Campania L. Vanvitelli, Naples, Italy., El-Kurdi M; Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom., Garrido-Mesa J; Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom., Cai CBB; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Cameron AJ; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Hanson AL; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Nel HJ; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Kenna T; Queensland University of Technology, Centre for Immunology and Infection Control, School of Biomedical Sciences, Queensland 4006, Australia., Leo P; Queensland University of Technology, Centre for Immunology and Infection Control, School of Biomedical Sciences, Queensland 4006, Australia., Rehaume L; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia., Brown MA; Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom; Genomics England Ltd, Charterhouse Square, London, United Kingdom., Ciccia F; Dipartimento di Medicina di Precisione, Section of Rheumatology, Università degli Studi della Campania L. Vanvitelli, Naples, Italy., Thomas R; Frazer Institute, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia. Electronic address: ranjeny.thomas@uq.edu.au.
Publikováno v:
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2023 Feb; Vol. 247, pp. 109220. Date of Electronic Publication: 2022 Dec 31.
Autor:
Ruffieux H; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. helene.ruffieux@mrc-bsu.cam.ac.uk., Hanson AL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Lodge S; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia., Lawler NG; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia., Whiley L; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, Australia., Gray N; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia., Nolan TH; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Bergamaschi L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Mescia F; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Turner L; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., de Sa A; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Pelly VS; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Kingston N; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, UK., Holmes E; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK., Wist J; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Chemistry Department, Universidad del Valle, Cali, Colombia., Nicholson JK; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.; Institute of Global Health Innovation, Imperial College London, London, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Richardson S; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Bantug GR; Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Botnar Research Centre for Child Health (BRCCH) University Basel & ETH Zurich, Basel, Switzerland., Hess C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. ch818@cam.ac.uk.; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. ch818@cam.ac.uk.; Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland. ch818@cam.ac.uk.; Botnar Research Centre for Child Health (BRCCH) University Basel & ETH Zurich, Basel, Switzerland. ch818@cam.ac.uk.
Publikováno v:
Nature immunology [Nat Immunol] 2023 Feb; Vol. 24 (2), pp. 349-358. Date of Electronic Publication: 2023 Jan 30.